Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | |
| Sales | 4,500 |
| Gross Profit | 4,500 |
| Operating Expenses | 9,416 |
| Operating Income | -4,916 |
| Interest Expense | 752 |
| Other Income | 261 |
| Pre-tax Income | -5,407 |
| Income Tax | 532 |
| Net Income Continuous | -5,939 |
| Net Income | $-5,939 |
| EPS Basic Total Ops | -36,407.04 |
| EPS Basic Continuous Ops | -36,407.04 |
| EPS Diluted Total Ops | -36,407.04 |
| EPS Diluted Continuous Ops | -36,407.04 |
| EBITDA(a) | $-4,488 |